Alliancebernstein L.P. Dice Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$25.86 - $46.71 $13.4 Million - $24.3 Million	519,547 Added 1618.53%	551,647 $25.6 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $135,460 - $168,012	5,200 Added 19.33%	32,100 $919,000
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $15,816 - $33,784	800 Added 3.07%	26,900 $839,000
Q3 2022 Nov 15, 2022	BUY	$14.97 - $22.65 $52,395 - $79,275	3,500 Added 15.49%	26,100 $529,000
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $298,094 - $499,460	22,600 New	22,600 $351,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.